Citius Oncology (CTOR) Stock Chart & Stock Price History $1.69 -0.03 (-1.74%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$1.72 +0.03 (+1.48%) As of 08/15/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Citius Oncology Stock Price Performance The Citius Oncology (CTOR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 15.50%, with a year-to-date return of 46.96%. In the past month, the stock has increased 7.64%, reflecting recent market activity. As of the latest close, Citius Oncology traded at $1.69 with a market cap of $132.45 million and volume of 59,776 shares. Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.74%1 Month Performance+7.64%3 Month Performance+84.70%Year-To-Date Performance+46.96%1 Year Performance-15.50% CTOR Stock Chart for Saturday, August, 16, 2025 CTOR Chart by TradingView Citius Oncology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$1.72$1.69-1.74%$1.76$1.6659,776 shs$132.45 million08/14/2025$1.79$1.72-3.91%$1.87$1.62277,236 shs$134.80 million08/13/2025$1.69$1.79+5.92%$1.80$1.70168,659 shs$140.28 million08/12/2025$1.72$1.69-1.74%$1.77$1.67133,639 shs$132.45 million08/11/2025$1.81$1.72-4.97%$1.85$1.71174,158 shs$134.80 million08/08/2025$1.85$1.81-2.16%$1.94$1.74158,296 shs$141.85 million08/07/2025$1.91$1.85-3.14%$1.99$1.75230,639 shs$149.69 million08/06/2025$1.81$1.91+5.52%$2.04$1.88271,065 shs$149.69 million08/05/2025$2.06$1.81-12.14%$2.06$1.81365,870 shs$141.85 million08/04/2025$2.06$2.06$2.12$2.05192,774 shs$161.44 million Get the Latest News and Ratings for CTOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$2.21$2.06-6.79%$2.31$2.06608,706 shs$161.44 million07/31/2025$2.16$2.21+2.31%$2.33$2.19382,703 shs$173.20 million07/30/2025$2.06$2.16+4.85%$2.37$2.061.34 million shs$169.28 million07/29/2025$1.87$2.06+10.16%$2.30$1.821.62 million shs$161.44 million07/28/2025$1.97$1.87-5.08%$2.00$1.75565,431 shs$146.55 million07/25/2025$1.95$1.97+1.03%$2.38$1.952.28 million shs$154.39 million07/24/2025$1.82$1.95+7.14%$1.99$1.811.13 million shs$152.82 million07/23/2025$1.65$1.82+10.30%$2.84$1.7019.53 million shs$142.64 million07/22/2025$1.48$1.65+11.49%$1.70$1.47432,580 shs$118.06 million07/21/2025$1.53$1.48-3.27%$1.59$1.47342,255 shs$105.89 million07/18/2025$1.60$1.53-4.38%$1.72$1.52573,376 shs$109.47 million07/17/2025$1.57$1.60+1.91%$1.76$1.551.15 million shs$114.48 million07/16/2025$1.54$1.57+1.95%$1.82$1.3516.17 million shs$112.33 million07/15/2025$1.94$1.54-20.62%$2.09$1.541.40 million shs$110.19 million Related Companies Maravai LifeSciences Stock Chart Keros Therapeutics Stock Chart Bicara Therapeutics Stock Chart Relay Therapeutics Stock Chart Tyra Biosciences Stock Chart Sage Therapeutics Stock Chart Upexi Stock Chart Tourmaline Bio Stock Chart Terns Pharmaceuticals Stock Chart Rapport Therapeutics Stock Chart Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTOR) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access